Sort Through Options for ESBL, CRE, and Resistant Pseudomonas
We’re getting questions about how to treat multidrug-resistant (MDR) gram-negative infections.
These infections are often caused by extended-spectrum beta-lactamase (ESBL) producers...carbapenem-resistant Enterobacterales (CRE)...or Pseudomonas with “difficult-to-treat resistance” (DTR).
Be ready to answer questions and work with your ID team.Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote